167 related articles for article (PubMed ID: 15779341)
21. Impaired fasting glucose (IFG) versus impaired glucose tolerance (IGT): the present scenario.
Kundu AK
J Assoc Physicians India; 2000 May; 48(5):551-2. PubMed ID: 11273166
[No Abstract] [Full Text] [Related]
22. Inadequacies of absolute threshold levels for diagnosing prediabetes.
Bergman M
Diabetes Metab Res Rev; 2010 Jan; 26(1):3-6. PubMed ID: 20101658
[TBL] [Abstract][Full Text] [Related]
23. [Natural history of glucose intolerance groups].
Ito C
Nihon Rinsho; 2005 Feb; 63 Suppl 2():63-6. PubMed ID: 15779346
[No Abstract] [Full Text] [Related]
24. [Definition and diagnosis of IFG, IGT and borderline type].
Kawazu S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():43-8. PubMed ID: 15779343
[No Abstract] [Full Text] [Related]
25. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm.
Deedwania PC; Fonseca VA
Am J Med; 2005 Sep; 118(9):939-47. PubMed ID: 16164876
[TBL] [Abstract][Full Text] [Related]
26. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study.
Magliano DJ; Barr EL; Zimmet PZ; Cameron AJ; Dunstan DW; Colagiuri S; Jolley D; Owen N; Phillips P; Tapp RJ; Welborn TA; Shaw JE
Diabetes Care; 2008 Feb; 31(2):267-72. PubMed ID: 17989310
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
Muntner P; He J; Chen J; Fonseca V; Whelton PK
Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
[TBL] [Abstract][Full Text] [Related]
29. Impaired glucose tolerance--fact or fiction.
Alberti KG
Diabet Med; 1996; 13(3 Suppl 2):S6-8. PubMed ID: 8689861
[TBL] [Abstract][Full Text] [Related]
30. [Impaired glucose tolerance (IGT): current understanding and future research directions].
Terauchi Y; Kadowaki T
Nihon Rinsho; 2005 Feb; 63 Suppl 2():21-6. PubMed ID: 15779340
[No Abstract] [Full Text] [Related]
31. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India.
Ramachandran A; Mary S; Yamuna A; Murugesan N; Snehalatha C
Diabetes Care; 2008 May; 31(5):893-8. PubMed ID: 18310309
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of ADA and WHO diagnostic criteria for diabetes diagnosis and other categories of glucose intolerance ].
Herdzik E; Safranow K; Ciechanowski K; Byra E; Gołdyn U
Pol Merkur Lekarski; 2002 Oct; 13(76):316-20. PubMed ID: 12557440
[TBL] [Abstract][Full Text] [Related]
33. Reduction of body iron stores and the prevention of type 2 diabetes.
Mascitelli L; Pezzetta F
Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
[No Abstract] [Full Text] [Related]
34. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
[TBL] [Abstract][Full Text] [Related]
35. Comparison of WHO and ADA criteria for diagnosis of glucose status in adults.
Metcalf PA; Scragg RK
Diabetes Res Clin Pract; 2000 Aug; 49(2-3):169-80. PubMed ID: 10963829
[TBL] [Abstract][Full Text] [Related]
36. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
[TBL] [Abstract][Full Text] [Related]
37. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
Mohan V; Shanthirani CS; Deepa R
J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
[TBL] [Abstract][Full Text] [Related]
38. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
Ko GT; Cockram CS; Chan JC
J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
[TBL] [Abstract][Full Text] [Related]
39. Reflecting on type 2 diabetes prevention: more questions than answers!
Rosenstock J
Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():3-11. PubMed ID: 17877541
[TBL] [Abstract][Full Text] [Related]
40. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
